{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:54:40Z","timestamp":1775091280877,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10067-019-04474-9","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T19:21:29Z","timestamp":1554924089000},"page":"2825-2833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Infliximab for the treatment of refractory polyarteritis nodosa"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-4484","authenticated-orcid":false,"given":"Shira","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gleb","family":"Slobodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar","family":"Jiries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Boulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abid","family":"Awisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haya","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Novofastovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Silawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Rimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"4474_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"4474_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","volume":"15","author":"A Virgilio De","year":"2016","unstructured":"De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, Martellucci S, de Vincentiis M (2016) Polyarteritis nodosa: a contemporary overview. Autoimmun Rev 15:564\u2013570","journal-title":"Autoimmun Rev"},{"key":"4474_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1191\/096120398678920055","volume":"7","author":"F Lhote","year":"1998","unstructured":"Lhote F, Cohen P, Guillevin L (1998) Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 7:238\u2013258","journal-title":"Lupus"},{"key":"4474_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P (2011) The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 90:19\u201327","journal-title":"Medicine"},{"key":"4474_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Aym\u00e9 S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92\u201399","journal-title":"Arthritis Rheum"},{"key":"4474_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","volume":"74","author":"L Guillevin","year":"1995","unstructured":"Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, No\u00ebl LH, Tr\u00e9po C (1995) Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74:238\u2013253","journal-title":"Medicine (Baltimore)"},{"key":"4474_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/rheumatology\/kel091","volume":"45","author":"D Selga","year":"2006","unstructured":"Selga D, Mohammad A, Sturfelt G, Segelmark M (2006) Polyarteritis nodosa when applying the Chapel Hill nomenclature\u2014a descriptive study on ten patients. Rheumatology (Oxford) 45:1276\u20131281","journal-title":"Rheumatology (Oxford)"},{"key":"4474_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.rbr.2016.04.009","volume":"57","author":"KA Teles","year":"2017","unstructured":"Teles KA, Medeiros-Souza P, Lima FAC, Ara\u00fajo BG, Lima RAC (2017) Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review. Rev Bras Reumatol Engl Ed 57:596\u2013604","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"4474_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/art.1780380815","volume":"38","author":"CD Radis","year":"1995","unstructured":"Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A et al (1995) Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year follow-up study. Arthritis Rheum 38:1120\u20131127","journal-title":"Arthritis Rheum"},{"key":"4474_CR10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2169\/internalmedicine.56.8235","volume":"56","author":"S Matsuo","year":"2017","unstructured":"Matsuo S, Hayashi K, Morimoto E, Sada KE, Watanabe H, Takano-Narazaki M et al (2017) The successful treatment of refractory polyarteritis nodosa using infliximab. Intern Med 56:1435\u20131438","journal-title":"Intern Med"},{"issue":"1","key":"4474_CR11","doi-asserted-by":"publisher","first-page":"e000446","DOI":"10.1136\/rmdopen-2017-000446","volume":"3","author":"A Saunier","year":"2017","unstructured":"Saunier A, Issa N, Vandenhende MA, Morlat P, Doutre MS, Bonnet F (2017) Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach? RMD Open 3(1):e000446","journal-title":"RMD Open"},{"key":"4474_CR12","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1136\/annrheumdis-2016-209330","volume":"75","author":"D Rimar","year":"2016","unstructured":"Rimar D, Alpert A, Starosvetsky E, Rosner I, Slobodin G, Rozenbaum M, Kaly L, Boulman N, Awisat A, Ginsberg S, Zilber K, Shen-Orr SS (2016) Tofacitinib for polyarteritis nodosa: a tailored therapy. Ann Rheum Dis 75:2214\u20132216","journal-title":"Ann Rheum Dis"},{"key":"4474_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3109\/14397595.2015.1014153","volume":"27","author":"Y Sery","year":"2017","unstructured":"Sery Y, Shoda H, Hanata N, Nagafuch Y, Sumitomo S, Fujio K et al (2017) A case of refractory polyarteritis nodosa successfully treated with rituximab. Mod Rheumatol 27:696\u2013698","journal-title":"Mod Rheumatol"},{"key":"4474_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/rheumatology\/kep148","volume":"48","author":"D Eleftheriou","year":"2009","unstructured":"Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, Dolezalova P, Ozen S, Pilkington C, Woo P, Klein N, Dillon MJ, Brogan PA (2009) Biologic therapy in primary systemic vasculitis of the young. Rheumatology 48:978\u2013986","journal-title":"Rheumatology"},{"key":"4474_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/art.1780330805","volume":"33","author":"RW Lightfoot Jr","year":"1990","unstructured":"Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088\u20131093","journal-title":"Arthritis Rheum"},{"key":"4474_CR16","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P (1999) Infliximab (chimeric anti-tumour necrosis factor-\u03b1 monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 354:1932\u20131939","journal-title":"Lancet"},{"key":"4474_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2014.01.029","volume":"48-49","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2014","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J, Alba MA, Prieto-Gonz\u00e1lez S, Cid MC (2014) Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48-49:84\u201389","journal-title":"J Autoimmun"},{"key":"4474_CR18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1468-3083.2006.01967.x","volume":"21","author":"J Vega Gutierrez","year":"2007","unstructured":"Vega Gutierrez J, Rodriguez Prieto MA, Garcia Ruiz JM (2007) Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab. J Eur Acad Dermatol Venereol 21:570\u2013571","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4474_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fphar.2014.00122","volume":"5","author":"M Capuozzo","year":"2014","unstructured":"Capuozzo M, Ottaiano A, Nava E, Cascone S, Fico R, Laffaioli RV et al (2014) Etanercept induces remission of polyarteritis nodosa: a case report. Front Pharmacol 5:122","journal-title":"Front Pharmacol"},{"key":"4474_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jbspin.2013.11.009","volume":"81","author":"R Campanilho-Marques","year":"2014","unstructured":"Campanilho-Marques R, Ramos F, Canh\u00e3o H, Fonseca JE (2014) Remission induced by infliximab in a childhood polyarteritis nodosa refractory to conventional immunosuppression and rituximab. Joint Bone Spine 81:267\u2013268","journal-title":"Joint Bone Spine"},{"key":"4474_CR21","first-page":"2","volume":"16","author":"F Uettwiller","year":"2016","unstructured":"Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y et al (2016) ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open 16:2","journal-title":"RMD Open"},{"key":"4474_CR22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3109\/s10165-012-0732-8","volume":"23","author":"T Zoshima","year":"2013","unstructured":"Zoshima T, Matsumura M, Suzuki Y, Kakuchi Y, Mizushima I, Fujii H, Yamada K, Yamagishi M, Kawano M (2013) A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade. Mod Rheumatol 23:1029\u20131033","journal-title":"Mod Rheumatol"},{"key":"4474_CR23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfk082","volume":"21","author":"K Wu","year":"2006","unstructured":"Wu K, Throssell D (2006) A new treatment for polyarteritis nodosa. Nephrol Dial Transplant 21:1710\u20131712","journal-title":"Nephrol Dial Transplant"},{"key":"4474_CR24","first-page":"1371","volume":"32","author":"J Al-Bishri","year":"2005","unstructured":"Al-Bishri J, le Riche N, Pope JE (2005) Refractory polyarteritis nodosa successfully treated with infliximab. J Rheumatol 32:1371\u20131373","journal-title":"J Rheumatol"},{"key":"4474_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10067-005-0071-7","volume":"25","author":"SW Kort De","year":"2006","unstructured":"De Kort SW, van Rossum MA, ten Cate R (2006) Infliximab in a child with therapy-resistant systemic vasculitis. Clin Rheumatol 25:769\u2013771","journal-title":"Clin Rheumatol"},{"key":"4474_CR26","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA (2016) Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheum 68:2314\u20132322","journal-title":"Arthritis Rheum"},{"key":"4474_CR27","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.1542\/peds.2009-3331","volume":"126","author":"DM Wahezi","year":"2010","unstructured":"Wahezi DM, Gomes WA, Ilowite NT (2010) Cranial nerve involvement with juvenile polyarteritis nodosa: clinical manifestations and treatment. Pediatrics 126:e719\u2013e722","journal-title":"Pediatrics"},{"key":"4474_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12659\/MSM.881308","volume":"17","author":"AP Rozin","year":"2011","unstructured":"Rozin AP, Egozi D, Ramon Y, Toledano K, Braun-Moscovici Y, Markovits D et al (2011) Large leg ulcers due to autoimmune diseases. Med Sci Monit 17:1\u20137","journal-title":"Med Sci Monit"},{"key":"4474_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkam","year":"2014","unstructured":"Navon Elkam P, Pierce SB, Segal R, Walsh T, Barash J, Padeh S (2014) Mutant adenosine deaminase 2 in polyarteritis nodosa vasculopathy. N Engl J Med 370:921\u2013931","journal-title":"N Engl J Med"},{"key":"4474_CR30","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/art.20300","volume":"50","author":"GS Hoffman","year":"2004","unstructured":"Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti\u2013tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50:2296\u20132304","journal-title":"Arthritis Rheum"},{"key":"4474_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/493593","volume":"2014","author":"PA Jarrot","year":"2014","unstructured":"Jarrot PA, Kaplanski G (2014) Anti-TNF-alpha therapy and systemic Vasculitis. Mediat Inflamm 2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/493593","journal-title":"Mediat Inflamm"},{"key":"4474_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/BOR.0b013e32831d28b3","volume":"21","author":"SA Chang","year":"2009","unstructured":"Chang SA, Seo P (2009) Advances in the use of biologic agents for the treatment of systemic vasculitis. Curr Opin Rheumatol 21:3\u20139","journal-title":"Curr Opin Rheumatol"},{"key":"4474_CR33","first-page":"196","volume":"68","author":"GE Grau","year":"1989","unstructured":"Grau GE, Roux-Lombard P, Gysler C, Lambert C, Lambert PH, Dayer JM (1989) Serum cytokine in systemic vasculitis. Immunology 68:196\u2013198","journal-title":"Immunology"},{"key":"4474_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2249.1990.tb03336.x","volume":"81","author":"Y Deguchi","year":"1990","unstructured":"Deguchi Y, Shibata N, Kishimoto S (1990) Enhanced expression of the tumor necrosis factor\/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol 81:311\u2013314","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04474-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T20:14:55Z","timestamp":1721160895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04474-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4474"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04474-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"30 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}